End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,320 KRW | -4.13% | -10.25% | -3.13% |
Business Summary
Number of employees: 115
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-clinical Trial
53.5
%
| 10,386 | 63.7 % | 6,791 | 53.5 % | -34.61% |
Cosmetics
32.4
%
| 4,009 | 24.6 % | 4,117 | 32.4 % | +2.69% |
Stem Cell
11.4
%
| 1,343 | 8.2 % | 1,444 | 11.4 % | +7.54% |
Biopharma
2.8
%
| 563 | 3.5 % | 351 | 2.8 % | -37.54% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 16,301 | 100.0 % | 12,704 | 100.0 % | -22.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Chun Na
CEO | Chief Executive Officer | 61 | - |
Seung-Hee Lee
CTO | Chief Tech/Sci/R&D Officer | 43 | - |
Seung-Won Im
AUD | Comptroller/Controller/Auditor | 64 | - |
Myung-Kwan Seo
PRN | Corporate Officer/Principal | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yong-Ho Park
BRD | Director/Board Member | 68 | - |
Jung-Ho Choi
BRD | Director/Board Member | 63 | - |
Sang-Kyun Lee
BRD | Director/Board Member | 71 | - |
Yo-Han Bae
BRD | Director/Board Member | 56 | - |
Jong-Chun Na
CEO | Chief Executive Officer | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 67,499 | 0 | 0 | 85.70 % |
Stock B | 1 | 55,937,925 | 47,937,111 ( 85.70 %) | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-3.13% | 95.91M | |
+35.90% | 50.93B | |
-0.41% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.11% | 26.02B | |
-22.01% | 18.9B | |
+7.37% | 13.21B | |
+24.45% | 12.17B | |
+28.95% | 12.16B |
- Stock Market
- Equities
- A217730 Stock
- Company Kangstem Biotech Co., Ltd.